Pharma, are you ready? While Inflation Reduction Act (IRA) has officially turned one, few in or industry has yet understand the implications of the IRA on future drug development. Changes to the IRA’s drug price negotiation and Part D redesign will affect strategic investments and operational preparations. If you need to how this will your product portfolio, I suggest signing up for this! #AvalereWebinar
UPDATE: POSTPONED. We apologize for any inconvenience and will announce a new date soon. If you have already registered, your registration will be transferred to the new date. Thank you for your understanding.
